ABC Money
Home

Medtronic: spine surgery shows benefit


Published :
Thu, 31 May 2007 20:53
By : Agencies
Print this Story


AddThis Social Bookmark Button

MINNEAPOLIS (AP) - Medtronic Inc., which had more than $2.4 billion in spinal product sales in fiscal 2007, called attention on Thursday to a government study that found surgical treatments for certain types of lower-back pain were more effective than non-surgical options.

The results of the National Institutes of Health-sponsored study, which appeared in the New England Journal of Medicine, followed 607 Medicare patients suffering from a painful condition in which pressure builds on spinal nerves after a vertebrae slips out of place. The condition is known as degenerative spondylolisthesis with spinal stenosis.

One group of patients was given surgery to fuse the troubled vertebrae together, a procedure that often uses a spinal device to keep bones immobile while they heal. The other group received standard nonsurgical treatments. Patients were monitored as early as 6 weeks from beginning the study out to 2 years.

Those given the surgery showed a substantially greater improvement when patients were treated surgically based on quality of life assessments versus non-surgically, the study concluded.

Spinal product sales accounted for $2.42 billion of Medtronic's $12.3 billion in fiscal 2007 revenue.

Medtronic shares rose 7 cents to $53.07 in afternoon trading.

Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.




Share on


 You Might Like
Medtronic to buy Breakaway Imaging
Medtronic 4Q profits rise 10 percent
+
The eyes of a Tiger are adjusted _ again
Novartis study says Glivec helps stop stomach cancer tumour recur after surgery

Comment on this Article
Comment:
Title:
Name:
Please Enter
 
Here
  

 Search News

 Look For
Business
Credit cards
Finance
Loans
Money
Mortgages

 
 Stock Quotes *
SYMBOL
LAST
CHANGE
DOW JONES
8419.09
+270.00 ( 3.31 %)
NASDAQ
1449.80
+51.73 ( 3.63 %)
FTSE 100
4122.86
+57.37 ( 1.41 %)

SYMBOL ( 2008-12-02 )
LAST
CHANGE
RECKITT BENCKISER ( 11:35am )
2684.00
+70.00 ( 2.69 %)
ASTRAZENECA ( 11:35am )
2475.00
+55.00 ( 2.31 %)
BRITISH AMERICAN TOBACCO ( 11:35am )
1651.00
+51.00 ( 3.22 %)
CARNIVAL ( 11:35am )
1347.00
+51.00 ( 4.02 %)
ROYAL DUTCH SHELL-B ( 11:35am )
1653.00
+47.00 ( 2.98 %)

SYMBOL ( 2008-12-02 )
LAST
CHANGE
EXXON MOBIL CORP ( 4:02pm )
77.61
+3.30 ( 4.37 %)
IBM ( 4:01pm )
79.84
+2.94 ( 3.78 %)
JP MORGAN CHASE CO ( 4:01pm )
28.53
+2.41 ( 9.08 %)
GEN ELECTRIC CO ( 4:02pm )
17.61
+2.11 ( 13.07 %)
MERCK CO INC ( 4:02pm )
26.68
+1.83 ( 7.07 %)

SYMBOL ( 2008-12-02 )
LAST
CHANGE
ARDEN GROUP INC ( 4:00pm )
135.77
+11.04 ( 8.69 %)
DIAMOND HILL INV ( 4:00pm )
56.67
+10.42 ( 21.37 %)
GOOGLE ( 4:00pm )
275.11
+9.12 ( 3.37 %)
AMER NATL INS CO ( 4:00pm )
69.87
+8.96 ( 14.38 %)
ATRION CP ( 4:00pm )
95.29
+8.28 ( 9.10 %)

Gainers & Losers
Dow Jones
Euro Stoxx 50
FTSE 100
FTSE 250
FTSE AIM
FTSE ALL
Nasdaq

 Portfolio Manager

You must log in to access this area of the site. If you are not a registered user click here to sign up for instant access!


 Finance Explained

Money making ideas

Save money

Money management
Savings accounts
Investing money
Share dealing
Stock broker
Forex currency trading
Pension plans
Functions of Money

(c) 2007 ABCmoney.co.uk, All Rights Reserved
*ABCMoney.co.uk does not guarantee the accuracy of any share prices or stock quotations displayed. These are not real time quotes; all are delayed by at least twenty minutes and are for information purposes only.